SGLT-2 inhibitors show mixed results after heart attack
Meeting Announcement
Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology’s Annual Scientific Session.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology’s Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.
Zhao and her students hosted the AIM3DP Boot Camp the Carnegie Science Center BNY Mellon Mobile Fab Lab from March 16–17 as part of Zhao's NSF CAREER award for young investigators (Award #: 2238557).
The Cardiovascular Research Foundation® (CRF®) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference. Taking place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City, the new summit will be a world-class educational experience in the field of structural heart interventions.
Leaders from the Mass General Cancer Center, a member of the Mass General Brigham healthcare system, will present research discoveries and outcomes from clinical trials in cancer at the 2024 American Association for Cancer Research (AACR) Annual Meeting, held April 5-10, in San Diego.
The leading research and educational conference for multiple sclerosis healthcare professionals in North America, the Consortium of Multiple Sclerosis Centers (CMSC) 38th Annual Meeting, returns to Nashville, Tennessee, May 29-June 1, 2024 at the Music City Center. The conference is renowned for its emphasis on reaching the interprofessional team involved in MS care, with learning opportunities for physicians, advanced practice clinicians, nursing professionals, pharmacists, mental health and rehabilitation specialists, dietitians, researchers, advocates and other members of the healthcare team involved in the management of people with MS.
The University of Copenhagen is excited to announce Insilico Medicine as Tier 1 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
The University of Copenhagen is excited to announce LongeVC as Tier 1 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.Space weather impacts satellites, communications, GPS and power grids. TESS unites the community dedicated to the study of the Sun and its interactions with Earth and the other worlds in the solar system.
The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Enhancing Positive Emotions to Prevent Depression in Youth” on Tuesday, April 9, 2024, at 2:00 pm ET, offering new insights on addressing depression in children and young adults. The presenter will be Autumn Kujawa, Ph.D., Associate Professor of Psychology and Human Development and Director of the Mood, Emotion, & Development Lab at Vanderbilt University. Dr. Kujawa is also the recipient of two BBRF Young Investigator Grants. Jeffrey Borenstein, M.D., President & CEO of the Brain & Behavior Research Foundation, and host of the public television series Healthy Minds will be the webinar host.
Complimentary press passes are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition.